Articles from Glancy Prongay Wolke & Rotter LLP

Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming June 23, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Regencell Bioscience Holdings Limited (“Regencell” or the “Company”) (NASDAQ: RGC) securities between October 28, 2024 and October 31, 2025, inclusive (the “Class Period”).

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Option Care Health, Inc. (“Option Care Health” or the “Company”) (NASDAQ: OPCH) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Regencell Bioscience Holdings Limited (“Regencell” or the “Company”) (NASDAQ: RGC) securities between October 28, 2024 and October 31, 2025, inclusive (the “Class Period”). Regencell investors have until June 23, 2026 to file a lead plaintiff motion.

Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming June 26, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired SES AI Corporation (“SES AI” or the “Company”) (NYSE: SES) securities between January 29, 2025 and March 4, 2026, inclusive (the “Class Period”).

Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming July 6, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired FS KKR Capital Corp. (“FS KKR Capital” or the “Company”) (NYSE: FSK) securities between May 8, 2024 and February 25, 2026, inclusive (the “Class Period”).

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of GeneDx Holdings Corp. (“GeneDx” or the “Company”) (NASDAQ: WGS) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay Wolke & Rotter LLP (“GPWR”), announces that it has filed a class action lawsuit in the United States District Court for the Eastern District of Pennsylvania, captioned Stuart v. FS KKR Capital Corp., et al., Case No. 2:26-cv-02969, on behalf of persons and entities that purchased or otherwise acquired FS KKR Capital Corp. (“FS KKR Capital” or the “Company”) (NYSE: FSK) securities between May 8, 2024 and February 25, 2026, inclusive (the “Class Period”). Plaintiff pursues claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the “Exchange Act”).

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired SES AI Corporation (“SES AI” or the “Company”) (NYSE: SES) securities between January 29, 2025 and March 4, 2026, inclusive (the “Class Period”). SES AI investors have until June 26, 2026 to file a lead plaintiff motion.

Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming June 23, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Globant S.A. (“Globant” or the “Company”) (NYSE: GLOB) common stock between February 15, 2024 and August 14, 2025, inclusive (the “Class Period”).

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Check Point Software Technologies Ltd. (“CHKP” or the “Company”) (NASDAQ: CHKP) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming June 22, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired LKQ Corporation (“LKQ” or the “Company”) (NASDAQ: LKQ) common stock between February 27, 2023 and July 23, 2025, inclusive (the “Class Period”).

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Regencell Bioscience Holdings Limited (“Regencell” or the “Company”) (NASDAQ: RGC) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Globant S.A. (“Globant” or the “Company”) (NYSE: GLOB) common stock between February 15, 2024 and August 14, 2025, inclusive (the “Class Period”). Globant investors have until June 23, 2026 to file a lead plaintiff motion.

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of SES AI Corporation (“SES AI” or the “Company”) (NYSE: SES) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Globant S.A. (“Globant” or the “Company”) (NYSE: GLOB) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired LKQ Corporation (“LKQ” or the “Company”) (NASDAQ: LKQ) common stock between February 27, 2023 and July 23, 2025, inclusive (the “Class Period”). LKQ investors have until June 22, 2026 to file a lead plaintiff motion.

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of LKQ Corporation (“LKQ” or the “Company”) (NASDAQ: LKQ) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Calix, Inc. (“CALX” or the “Company”) (NYSE: CALX) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Sportradar Group AG (“Sportradar” or the “Company”) (NASDAQ: SRAD) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, continues its investigation on behalf of Banco Santander, S.A. (“Banco Santander” or the “Company”) (NYSE: SAN) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, continues its investigation on behalf of PROCEPT BioRobotics Corporation (“Procept” or the “Company”) (NASDAQ: PRCT) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, continues its investigation on behalf of Barclays PLC (“Barclays” or the “Company”) (NYSE: BCS) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, continues its investigation on behalf of Via Transportation, Inc. (“Via” or the “Company”) (NYSE: VIA) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, continues its investigation on behalf of Distribution Solutions Group, Inc. (“Distribution Solutions” or the “Company”) (NASDAQ: DSGR) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, continues its investigation on behalf of TruBridge, Inc. (“TruBridge” or the “Company”) (NASDAQ: TBRG) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, continues its investigation on behalf of Arq, Inc. (“Arq” or the “Company”) (NASDAQ: ARQ) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, continues its investigation on behalf of OneMain Holdings, Inc. (“OneMain” or the “Company”) (NYSE: OMF) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, continues its investigation on behalf of FS KKR Capital Corp. (“FS KKR” or the “Company”) (NYSE: FSK) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, continues its investigation on behalf of ADMA Biologics, Inc. (“ADMA” or the “Company”) (NASDAQ: ADMA) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, continues its investigation on behalf of The Simply Good Foods Company (“Simply Good” or the “Company”) (NASDAQ: SMPL) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, continues its investigation on behalf of PicS N.V., also known as PicPay Holdings (“PicPay” or the “Company”) (NASDAQ: PICS) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, continues its investigation on behalf of Vertical Aerospace Ltd. (“Vertical Aerospace” or the “Company”) (NYSE: EVTL) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of SunPower Inc. (“SunPower” or the “Company”) (NASDAQ: SPWR) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming June 8, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Stellantis N.V. (“Stellantis” or the “Company”) (NYSE: STLA) common stock between February 26, 2025 and February 5, 2026, inclusive (the “Class Period”).

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Veritone, Inc. (“Veritone” or the “Company”) (NASDAQ: VERI) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay Wolke & Rotter LLP is proud to announce that it has been ranked in Chambers USA California Spotlight Guide 2026. Chambers Spotlight California 2026 highlights 376 ranked firms across 9 regions and 45 distinct practice areas. Covering practice areas from Litigation and Mergers & Acquisitions to Media & Entertainment and Antitrust, the 2026 Guide highlights the standout firms in key practice areas.

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of PicS N.V., also known as PicPay Holdings (“PicPay” or the “Company”) (NASDAQ: PICS) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of The Simply Good Foods Company (“Simply Good” or the “Company”) (NASDAQ: SMPL) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming June 8, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Medpace Holdings, Inc. (“Medpace” or the “Company”) (NASDAQ: MEDP) common stock between April 22, 2025 and February 9, 2026, inclusive (the “Class Period”).

Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming June 9, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired United Homes Group, Inc. (“United Homes” or the “Company”) (NASDAQ: UHG) securities between May 19, 2025 and February 22, 2026, inclusive (the “Class Period”).

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Stellantis N.V. (“Stellantis” or the “Company”) (NYSE: STLA) common stock between February 26, 2025 and February 5, 2026, inclusive (the “Class Period”). Stellantis investors have until June 8, 2026 to file a lead plaintiff motion.

Glancy Prongay Wolke & Rotter LLP (“GPWR”) announces that it has filed a class action lawsuit in the United States District Court for the Southern District of New York, captioned Kadiyam v. United Homes Group, Inc., et al., Case No. 1:26-cv-02989, on behalf of persons and entities that purchased or otherwise acquired United Homes Group, Inc. (“United Homes” or the “Company”) (NASDAQ: UHG) securities between May 19, 2025 and February 22, 2026, inclusive (the “Class Period”). Plaintiff pursues claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the “Exchange Act”).

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Medpace Holdings, Inc. (“Medpace” or the “Company”) (NASDAQ: MEDP) common stock between April 22, 2025 and February 9, 2026, inclusive (the “Class Period”). Medpace investors have until June 8, 2026 to file a lead plaintiff motion.

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Stellantis N.V. (“Stellantis” or the “Company”) (NYSE: STLA) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming June 1, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Gossamer Bio, Inc. (“Gossamer” or the “Company”) (NASDAQ: GOSS) securities between June 16, 2025 and February 20, 2026, inclusive (the “Class Period”).

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Medpace Holdings, Inc. (“Medpace” or the “Company”) (NASDAQ: MEDP) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Gossamer Bio, Inc. (“Gossamer” or the “Company”) (NASDAQ: GOSS) securities between June 16, 2025 and February 20, 2026, inclusive (the “Class Period”). Gossamer investors have until June 1, 2026 to file a lead plaintiff motion.

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Gossamer Bio, Inc. (“Gossamer” or the “Company”) (NASDAQ: GOSS) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming May 29, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Pinterest, Inc. (“Pinterest” or the “Company”) (NYSE: PINS) securities between February 7, 2025 and February 12, 2026, inclusive (the “Class Period”).

Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming May 26, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired ImmunityBio, Inc. (“ImmunityBio” or the “Company”) (NASDAQ: IBRX) securities between January 19, 2026 and March 24, 2026, inclusive (the “Class Period”).

Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming June 1, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired New Era Energy & Digital, Inc. (“New Era Energy” or the “Company”) (NASDAQ: NUAI) f/k/a New Era Helium Inc. securities between November 6, 2024 and December 29, 2025, inclusive (the “Class Period”).

Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming May 18, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of Gemini Space Station, Inc. (“Gemini” or the “Company”) (NASDAQ: GEMI) investors who purchased Class A common stock pursuant and/or traceable to the Offering Documents issued in connection with the Company’s initial public offering conducted on or about September 12, 2025 (the “IPO” or “Offering”) and/or securities between September 12, 2025 and February 17, 2026, inclusive (the “Class Period”).

Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming May 22, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Coty Inc. (“Coty” or the “Company”) (NYSE: COTY) common stock between November 5, 2025 and February 4, 2026, inclusive (the “Class Period”).

Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming May 22, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Atara Biotherapeutics, Inc. (“Atara” or the “Company”) (NASDAQ: ATRA) securities between May 20, 2024 and January 9, 2026, inclusive (the “Class Period”).

Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming May 20, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Lufax Holding Ltd. (“Lufax” or the “Company”) (NYSE: LU) securities between April 7, 2023 and January 26, 2025, inclusive (the “Class Period”).

Glancy Prongay Wolke & Rotter LLP (“GPWR”), announces that it has filed a class action lawsuit in the United States District Court for the Western District of Texas, captioned Annonio v. New Era Energy & Digital, Inc., et al., Case No. 7:26-cv-00120, on behalf of persons and entities that purchased or otherwise acquired New Era Energy & Digital, Inc. (“New Era” or the “Company”) (NASDAQ: NUAI) f/k/a New Era Helium Inc. securities between November 6, 2024 and December 29, 2025, inclusive (the “Class Period”). Plaintiff pursues claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the “Exchange Act”).

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired ImmunityBio, Inc. (“ImmunityBio” or the “Company”) (NASDAQ: IBRX) securities between January 19, 2026 and March 24, 2026, inclusive (the “Class Period”). ImmunityBio investors have until May 26, 2026 to file a lead plaintiff motion.

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Pinterest, Inc. (“Pinterest” or the “Company”) (NYSE: PINS) securities between February 7, 2025 and February 12, 2026, inclusive (the “Class Period”). Pinterest investors have until May 29, 2026 to file a lead plaintiff motion.

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Vertical Aerospace Ltd. (“Vertical Aerospace” or the “Company”) (NYSE: EVTL) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of ImmunityBio, Inc. (“ImmunityBio” or the “Company”) (NASDAQ: IBRX) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Lufax Holding Ltd. (“Lufax” or the “Company”) (NYSE: LU) securities between April 7, 2023 and January 26, 2025, inclusive (the “Class Period”). Lufax investors have until May 20, 2026 to file a lead plaintiff motion.

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of Gemini Space Station, Inc. (“Gemini” or the “Company”) (NASDAQ: GEMI) investors who purchased Class A common stock pursuant and/or traceable to the Offering Documents issued in connection with the Company’s initial public offering conducted on or about September 12, 2025 (the “IPO” or “Offering”) and/or securities between September 12, 2025 and February 17, 2026, inclusive (the “Class Period”). Gemini investors have until May 18, 2026 to file a lead plaintiff motion.

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Atara Biotherapeutics, Inc. (“Atara” or the “Company”) (NASDAQ: ATRA) securities between May 20, 2024 and January 9, 2026, inclusive (the “Class Period”). Atara investors have until May 22, 2026 to file a lead plaintiff motion.

Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming May 26, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Super Micro Computer, Inc. (“Super Micro” or the “Company”) (NASDAQ:SMCI) securities between April 30, 2024 and March 19, 2026, inclusive (the “Class Period”).

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of ADMA Biologics, Inc. (“ADMA” or the “Company”) (NASDAQ: ADMA) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Coty Inc. (“Coty” or the “Company”) (NYSE: COTY) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Gemini Space Station, Inc. (“Gemini” or the “Company”) (NASDAQ: GEMI) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming May 11, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired ODDITY Tech Ltd. (“Oddity” or the “Company”) (NASDAQ: ODD) securities between February 26, 2025 and February 24, 2026, inclusive (the “Class Period”).

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of FS KKR Capital Corp. (“FS KKR” or the “Company”) (NYSE: FSK) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Atara Biotherapeutics, Inc. (“Atara” or the “Company”) (NASDAQ: ATRA) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Lufax Holding Ltd. (“Lufax” or the “Company”) (NYSE: LU) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay Wolke & Rotter LLP (“GPWR”), announces that it has filed a class action lawsuit in the United States District Court for the Northern District of California, captioned Bhuva v. Super Micro Computer, Inc., et al., Case No. 3:26-cv-02606, on behalf of persons and entities that purchased or otherwise acquired Super Micro Computer, Inc. (“Super Micro” or the “Company”) (NASDAQ: SMCI) securities between April 30, 2024 and March 19, 2026, inclusive (the “Class Period”). Plaintiff pursues claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the “Exchange Act”). Investors are hereby notified that they have 60 days from the date of this notice to move the Court to serve as lead plaintiff in this action.

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Arq, Inc. (“Arq” or the “Company”) (NASDAQ: ARQ) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming May 18, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Gartner, Inc. (“Gartner” or the “Company”) (NYSE: IT) common stock between February 4, 2025 and February 2, 2026, inclusive (the “Class Period”).

Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming May 19, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Power Solutions International, Inc. (“Power Solutions” or the “Company”) (NASDAQ: PSIX) securities between May 8, 2025 and March 2, 2026, inclusive (the “Class Period”).